PharmaCyte Biotech, Inc. (13) | Uncategorized (3)
- Description of Securities (Filed With SEC on August 10, 2021)
- Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated May 4, 2020 (Filed With SEC on September 11, 2020)
- Amendment No. 1 to Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated July 15, 2020 (Filed With SEC on September 11, 2020)
